}

Tender For Rate Contract For Group No.4, Injection, I.V.Fluids, Solutions., Delhi-Delhi

Municipal Corporation Of Delhi has published Tender For Rate Contract For Group No.4, Injection, I.V.Fluids, Solutions.. Submission Date for this Tender is 31-05-2024. Alkali Metals Tenders in Delhi Delhi. Bidders can get complete Tender details and download the document.




Tender Notice

42371317
Corrigendum : Tender For Rate Contract For Group No.4, Injection, I.V.Fluids, Solutions.
Open Tender
Indian
Delhi
Delhi
31-05-2024

Tender Documents

Additional Details Available on Click
✓ Tendering Authority
✓ Publication Document
(Tender Document / Tender Notice )

Tender Details

Rate Contract For Group No.4, Injection, I.V.Fluids, Solutions. Tender For The Supplies Of Drugs And Pharmaceuticals, Labchemicals, X Ray Films And Chemicals, Surgicalsutures And Dressings, Vaccines, Sera Etc. And General Items For The Year 2023 25. , Inj: 17 Hydroxy Progesterone Caproate500 Mg. , Inj: 17 Hydroxy Progesterone Caproate 250 Mg , Inj: Acyclovir 250 Mg. , Inj: Adenosine 6Mg/2Ml , Inj: Adrenaline 1:1000 , Inj: Amino Acid 10% , Infusion: Amio Acid Solution I.V , Inj: Amiodarone 150 Mg/3Ml , Inj: Anti Diptheria Serrum 10,000 I.U. Vial , Inj: Anti Rabies-Human Rabies Immunoglobin 2Ml (300 I.U.) Pfs , Inj: Anti Rabies-Immune Serum - 300 Iu/Ml (Equine) Immunoglobin , Inj: Anti Rabies-Monoclonal Antibodies , Inj: Anti Snake Serum(Polyvalent) , Inj: Benzathine Penicilline 12 Lakhs , Inj: Betamethasone 4 Mg. , Inj: Calcium Gluconate (10% W/V) , Inj: Carboprost Tromethamine 250 Mcg/Ml , Inj: Carboprost Tromethamine125 Mcg/Ml , Inj: Ceftriaxone Sodium 1000 Mg + Disodium Edetate 37 Mg + Sulbactum 500 Mg , Inj: Ceftriaxone Sodium 1000 Mg + Disodium Edetate 74 Mg + Sulbactum 1000 Mg , Inj: Dexamethasone Sod. Phosphate 4 Mg/ Ml. , Iv Fluid: Dextose 5% In Fractional Saline 0.45% (Ffs Technology) - Each 100 Ml. Contains - Dextrose Anhydrous Ip 5.0 Gm. + Sodium Chloride Ip 0.45 Gm. +Water For Inj Ip Qs. , Iv Fluid: Dextrose Inj Ip 10% (Ffs Technology) - Each 100 Ml. Contains - Dextrose Anhydrous Ip 10.0 Gm.+ Water For Inj Ip Qs. , Iv Fluid: Dextrose Inj Ip 25% (Ffs Technology) - Each 100 Ml. Contains - Dextrose Anhydrous Ip 25.0 Gm.+ Water For Inj Ip Qs. , Inj: Diazepam 5 Mg/ Ml , Inj: Diclofenac Sod,. 25 Mg/ Ml , Inj: Diclofenac Sodium 75 Mg/Ml, 1Ml Inj Iv Bolus, Surfactant Free Inj , Inj: Dicyclomine 10 Mg/ Ml , Inj: Dobutamine Hcl 250 Mg/ Vial , Inj: Dopamine 200 Mg/ Amp.. (40 Mg./Ml.) , Inj: Drotaverine 20 Mg/Ml , Inj: Drotaverine 40 Mg , Insulin: Dulagutide 1.5Mg , Inj: Each 0.9Ml Contains: Atosiban Acetateip Equivalent To Atosiban 6.75 Mgwater For Inj Ipq.S. , Inj: Each 0.9Ml Contains:Atosiban Acetateip Equivalent To Atosiban 37.5 Mgwater For Inj Ip Q.S. , Inj: Each Ml Contains Human Insulin Ip 100 Iu (30% As Soluble Insulin Inj And 70% As Isophane Insulin Inj) (Human Insulin Of Recombinant Dna Origin) , Inj: Each Ml Contains Human Insulin Ip 100 Iu (Human Insulin Of Recombinant Dna Origin) , Inj: Each Ml Contains Human Insulin Ip 100 Iu (Insulin, Human Of Recombinant Dna Origin) Inj , Inj: Each Ml Contains Human Insulin Ip 40 Iu (30% As Soluble Insulin Inj And 70% As Isophane Insulin Inj) (Human Insulin Of Recombinant Dna Origin) Inj , Inj: Each Ml Contains Human Insulin Ip 40 Iu (Human Insulin Of Recombinant Dna Origin) , Inj: Each Ml Contains Insulin Glargine (Rdna Origin) 100 Iu , Inj: Each Ml Contains Insulin Glargine (Rdna Origin) 100 Iu , Inj: Each Ml Contains Insulin Glargine (Rdna Origin) 100 Iu , Inj: Each Ml Of 50% Insulin Lispro And 50%Insulin Lispro Protamine Suspension Contins 100 I.U. (Equivalent To 3.5 Mg) Insulin Lispro I.P. (R-Dna Origin) , Inj: Each Ml Of Insulin Lispro Contains 100 I.U. (Equivalent To 3.5 Mg) Insulin Lispro I.P. (R-Dna Origin) , Inj: Enoxaparin In Prefilledsyringe In Strength Of 0.4 Ml , Inj: Enoxaparin In Prefilledsyringe In Strength Of 0.6 Ml , Inj: Erythropoitin 2000 Units(Recombinant (Human) , Inj: Erythropoitin 4000 Units(Recombinant (Human) , Inj: Ethamsylate 125 Mg/ Ml , Inj: Etophylline 169. 4 Mg + Theophylline 50.6 Mg Per 2 Ml. Amp. , Inj: Ferric Carboxymaltose ( Elemental Iron- 50 Mg/Ml) , Inj: Fondaparinoaux 2.5 Mg , Inj: Frusemide 10 Mg/Ml. , Inj: Hepatitis B Surface Antigen Recombinant/ 20 Mcg/ Ml. , Infusion: Human Albumin 20% , Inj: Human Chorionicgonadotropin 5000 Iu (Hormone) , Inj: Hydrocortisone Sod.Succinate 100 Mg/ Ml. , Inj: Hyoscinebutyl Bromide 20 Mg/ Ml , Inj: Insulin Aspart 100 Iu/Ml. (Insulin Analogue Short Acting) , Inj: Insulin Aspart 100U/Ml For Inj In 10Ml , Inj: Insulin Aspart 100U/Ml For Inj In 3Ml , Inj: Insulin Glargine 100Units/Ml , Inj: Insulin Lispro 25% + Lispro Protamine 75% , Inj: Iron Sucrose 100 Mg , Inj: Isoxsuprine 5 Mg/ Ml , Inj: Labetalol 5 Mg Per Ml. , Inj: Magnesium Sulphate 50%2 Ml / Amp , Iv Fluid: Mannitol Inj Ip 20% (Ffs Technology) - Each 100 Ml. Contains: - Mannitol Usp 20.00Gm. + Water For Inj Ip Q.S. , Inj : Mecobalamine 500Mcg , Inj: Methylergometrine Maleate 0.2 Mg/ Ml , Inj: Methylprednisolone 500 Mg , Inj: Metoclopromide 5 Mg/ Ml , Inj: Multivitamin Iv Containing Vit. C 500 Mg + Vit.A 10000 Iu + Vit. D 1000 Iu + B1 50 Mg + B2 14 Mg+ B6 15 Mg + Nicotinamide 100 Mg/ 10 Ml Vial , Inj: Ondansetron2mg/Ml. , Inj: Oxytocin Iv 5Iu , Infusion: Paracetamol 1000Mg/100Ml , Inj: Paracetamol 150 Mg/ Ml , Inj: Pentoprazole 40 Mg , Inj: Pheneramine Maleate 22.75 Mg/ Ml , Inj: Ranitidine Hcl 50Mg/ 2 Ml , Inj: Recombinant Anti Rho-D Immunoglobulin 300 Mcg/Ml , Inj: Recombinant Human Growth Hormone (Somatropin) 4 I.U. + Solvent For Recosrtuction (Water For Inj 1Ml) , Inj: Reteplase 10 Units (18 Mg.) (Powder) , Inj: Reteplase-Non-Glycosylatedtissue Plasminogen Activator (Tpa), 10 Units With Diluent And Syringe , Inj: Rituximab 500Mg/Vial 50 Ml , Inj: Secukinumab , Inj: Tenecteplase 40Mg / Vial Usfda/Emea Approved , Inj: Terlipressin 1Mg/10Ml , Inj: Tocilizumab 80 Mg/4 Ml , Inj : Tranexamic Acid 500 Mg/5 Ml , Inj: Triamcinolone Acetonide 10Mg/Ml , Inj: Triamcinolone Acetonide 40Mg/Ml , Inj: Vasopression 20 Iu/Ml , Inj: Vit D-3, 600000 Unit /Ml In Oil Base , Inj: Water For Inj Ip (Sterile)

Corrigendum Details

Sr No CorrigendumDate Corrignedum CorrigendumType NewSubmissionDate
1 05-Mar-2024 PREBID Date 16-04-2024
2 04-Apr-2024 Corrigendum Revised schedule and sample submission venue Date 31-05-2024

Key Value

Document Fees
INR 1500 /-
EMD
INR 100000.0 /-
Tender Value
Refer document

Attachment

FileName File Description File Size
783a504d-2791-4dde-b024-f8b7bc31900e.html Tender Notice 0 KB
BOQ_205067.xls Tender Document 0 KB
TENDERDOCUMNETS.pdf Tender Document 0 KB
Tendernotice_1.pdf Tender Document 0 KB
Disclaimer :
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
Tell us about your Product / Services,
We will Find Tenders for you

Copyright © 2024 · All Rights Reserved. Terms of Usage | Privacy Policy

For Tender Information Services Visit : TenderDetail